Your latest cannabis business info from Europe

Your latest cannabis business info from Europe


Can4Med – development on medical cannabis market in Poland

can4med poland cannabis medical

Can4Med S.A. Poland, a licensed medical distributor specialising in cannabis and cannabinoid medications, is making an impact in the European cannabis industry as it develops its reach and sets itself as a leading supplier of medical cannabis. Can4Med is establishing itself as a key participant in the market while maintaining the greatest standards of safety, quality, and legality with its recent successful importation and distribution of a large shipment of cannabis goods throughout Poland.

Can4Med expansion in Poland

Can4Med’s partnerships with foreign growers and producers are one of the main initiatives guiding the company’s development. Can4Med wants not only to expand its product line. They also want to meet the changing demands in Poland and elsewhere by working with these industry leaders. This strategy allows the business to provide a wide range of cannabis pharmaceuticals. It guarantees that patients will have access to the drugs they require.

Arkadiusz Piotrowicz is the CEO of Can4Med Poland. He expressed his excitement about the recent successes, stating:

“We are thrilled to have received another shipment of cannabis products, allowing us to continue serving the Polish market with the medicines they need. This achievement brings us closer to our vision of becoming a European cannabis hub, based in Poland, focused on providing patients with safe and effective high-quality cannabinoid medications.”

Can4Med Poland’s success cannot be fully given to the business. Can4Med’s path has been greatly supported by the cooperation and assistance of regulatory agencies, healthcare professionals, and other stakeholders. Together, they fought to increase patient access to medical cannabis products, enabling them to research alternative treatments to improve their general well-being.

Can4Med S.A.’s future

Can4Med Poland continues to be focused on its core values of integrity, transparency, and patient-centricity. It develops its position as a reliable supplier in the medical cannabis industry. Moreover Can4Med also works to establish itself as a cannabis centre in Europe. The business will continue to offer outstanding medical cannabis products. But they also want to advance knowledge about the therapeutic benefits of cannabinoids.

In conclusion, Can4Med Poland is growing as a major provider of medicinal cannabis. It wants to be a major cannabis centre in Europe. Can4Med is on a position to address the rising demand for medical cannabis in Poland and elsewhere. All thanks to its dedication to upholding the highest standards of safety, quality, and legality, as well as its collaborations with foreign growers and manufacturers. Moreover, Can4Med works with medical specialists and regulatory bodies. Thus they can enable patients to learn more about the advantages of medicinal cannabis.


Financing in medical cannabis sector: Dalgety, UK

CB21 Pharma extends EU GMP for cannabis-derived pharmaceuticals


Sustainability and growth in the hemp&cannabis industry: Synbiotic